Navigation Links
Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
Date:11/4/2010

undue reliance should not be placed on such statements.  Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements.  Important factors that could cause actual results to differ materially from these expectations include, among other things, market factors affecting the price and liquidity of Common Shares, the satisfaction by Valeant of applicable laws to allow it to establish the Plan, the satisfaction of applicable laws for dividend payments, as well as other risks and uncertainties set forth from time to time in the reports Valeant files with the SEC and the CSA.  

Valeant cautions that the foregoing list of important factors that may affect future results is not exhaustive.  When relying on forward-looking statements to make decisions with respect to Valeant, investors and others should carefully consider the foregoing factors and other uncertainties and potential events.

Valeant does not undertake any obligation to update or revise any forward-looking statement, except as may be required by law.

(Logo:  http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20101025/LA87217LOGO)Contact Information:Contact for ValeantLaurie W. Little949-461-6002 laurie.little@valeant.com
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
2. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
3. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
4. Valeant and Biovail Announce Results of Special Meetings of Shareholders
5. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
6. Valeant to Acquire Polish Products
7. Pfizer Declares an 18-Cent Fourth-Quarter 2010 Dividend
8. Techne Corporation Declares Dividend
9. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend
10. Mylan Declares Quarterly Preferred Stock Dividend
11. Lilly Declares Fourth-Quarter 2010 Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Cogentix Medical, Inc. (NASDAQ: CGNT ), a ... release financial results for the first quarter of fiscal year ... on Monday, August 10, 2015. The Company ... results on Monday, August 10, 2015 at 4:30 p.m. Eastern ... and Chief Executive Officer, and Brett Reynolds , Chief ...
(Date:7/29/2015)... 29, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for ... announced that it will release Second Quarter financial ... 2015. AcelRx management will host an investment-community conference ... Pacific Time) on Aug 3rd, 2015 to discuss ...
(Date:7/29/2015)... , July 29, 2015  Efforts to improve working ... of pharmaceutical firms in North America ... is that an effective working capital management will ease ... patent cliffs. Big pharma companies expect to invest in ... Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO Analysis ...
Breaking Medicine Technology:Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4
... Clinicians Concerned About ... Exposure When Using an Oral NSAID, TAMPA, Fla., ... leading global specialty pharmaceutical company, announced today that two,studies ... Society annual,meeting demonstrate the efficacy, tolerability and positive pharmacokinetic,profile ...
... Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) announced ... 1 clinical trial of a drug candidate under ... treat psychiatric disorders.,The drug candidate is a novel ... psychiatric disorder., "We are very happy to ...
Cached Medicine Technology:Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 2Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 4Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 5Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 6Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 7Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 2Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 3
(Date:7/29/2015)... ... ... " mybody ” was featured on NewsWatch as part of its monthly ... impact in their industry. Andrew Tropeano, the host of NewsWatch and business expert, conducted ... designed to strengthen the skin’s defense system from the inside out. , According to ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... entered into a partnership with 247Ergo, an ergonomics specialty firm. Purpose of the ... projects that the companies undertake could improve worker mobility, functionality and fitness levels. ...
(Date:7/29/2015)... Washington, DC (PRWEB) , ... July 29, 2015 ... ... and aluminum-related illnesses is seeking funding for a study on the potentially lifesaving ... Safety Research Institute today . , The research proposal is based on ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Hernia repairs ... advanced as a result. Information provided by the National Center for Health Statistics ... and three million new cases are reported annually. While the only effective treatment for ...
(Date:7/29/2015)... ... July 29, 2015 , ... Nature’s Artisan, a new ... of gourmet flavors. , Nature’s Artisan was founded by Tina Yarandi, who came up ... the UCLA School of Dentistry. Tina was amazed when she learned about the incredible ...
Breaking Medicine News(10 mins):Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2
... HealthDay Reporter , WEDNESDAY, Nov. 9 (HealthDay News) ... typically subject to a mandatory six-month "dry-out" period before ... of the sickest of these patients fail to survive ... transplants can dramatically improve survival odds in those whose ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, Nov. ... has shown promise in patients with solid tumors, in this ... a trial of this experimental treatment, two had a complete ... is still alive more than four years after starting therapy. ...
... 2011 Non-adherence to antiplatelet therapy which ... was associated with higher rates of both ... of the PARIS registry were presented today at ... symposium, sponsored by the Cardiovascular Research Foundation. ...
... an estimated 1.5 million species, fungi represent one of the ... have an enormous impact on human affairs and ecosystem functioning ... their partnership with host organisms for mutual benefit. To ... of what exactly they do, how they function, and how ...
... NOVEMBER 9, 2011 Eric J. Topol, MD, a ... Career Achievement Award in a ceremony held today during ... sponsored by the Cardiovascular Research Foundation (CRF). The ... the field of interventional cardiovascular medicine. One ...
... the giver, not just the recipient, a new brain-imaging study ... talk about the ways in which social support is good ... social support come from the support we receive from others, ... benefits of social support actually come from the support we ...
Cached Medicine News:Health News:Study Supports Shorter Wait Time for Alcoholics Seeking Liver Transplant 2Health News:Study Supports Shorter Wait Time for Alcoholics Seeking Liver Transplant 3Health News:New Treatment May Boost Survival in Advanced Lung Cancer Cases 2Health News:New Treatment May Boost Survival in Advanced Lung Cancer Cases 3Health News:Results of the PARIS registry Reported at TCT 2011 2Health News:International team to sequence genomes of fungi 2Health News:International team to sequence genomes of fungi 3Health News:Eric J. Topol, M.D. presented with 2011 TCT Career Achievement Award 2Health News:'Tis better to give than to receive? 2Health News:'Tis better to give than to receive? 3
S.O.C. Medium...
... The Evolve™ modular radial head system ... and clinical research to create the next ... creating a two part, modular design, the ... to appropriately match the patients anatomy. In ...
This legless table has adjustable height and round post. Pad sold separately....
This table has a rectangular top, adjustable height, integral leg, and rail clamp.,Standard 2" (5 cm) pad included....
Medicine Products: